Skip to main content

Table 5 Microorganisms responsible for VAP

From: Relationship between corticosteroid use and incidence of ventilator-associated pneumonia in COVID-19 patients: a retrospective multicenter study

 

No corticosteroids

(n = 138)

Corticosteroids

(n = 74)

Gram-positive cocci

22 (15.9)

13 (17.6)

 MSSA

12 (8.8)

7 (9.5)

 MRSA

5 (3.6)

0 (0.0)

 Enterococcus spp.

3 (2.2)

4 (5.4)

 Streptococcus pneumoniae

2 (1.5)

2 (2.7)

Gram-negative bacilli

83 (60)

44 (59.5)

 Pseudomonas aeruginosa

24 (17.5)

17 (23)

 Enterobacter spp.

20 (14.6)

14 (18.9)

 Klebsiella pneumoniae

6 (4.4)

5 (6.8)

 Escherichia coli

12 (8.8)

2 (2.7)

 Acinetobacter baumannii

9 (6.6)

2 (2.7)

 Stenotrophomonas maltophilia

2 (1.5)

0 (0.0)

 Serratia marcescens

2 (1.5)

2 (2.7)

 Citrobacter freundii

4 (2.9)

0 (0.0)

 Proteus mirabilis

1 (0.7)

1 (1.4)

 Haemophilus influenza

2 (1.5)

0 (0.0)

 Morganella morganii

1 (0.7)

1 (1.4)

Other*

17 (12.3)

9 (12.1)

Polymicrobial

15 (10.9)

8 (10.8)

Multidrug-resistant isolates

26 (19.0)

21 (28.4)

  1. VAP Ventilator-associated pneumonia
  2. Values are as no. (%)
  3. Missing values n = 1 (in the no-corticosteroid group)
  4. MRSA, methicillin-resistant Staphylococcus aureus; MSSA, methicillin-sensitive Staphylococcus aureus
  5. *Contains other Streptococcus Spp., other Klebsiella Spp., other Citrobacter Spp. and other bacteria